Genomic vision develops novel diagnostic and drug discovery solutions based on nanotechnology for DNA analysis for cancer and acute diseases.
Business Model:
Revenue: $2.7M
Employees: 11-50
Address: 80-84 rue des Meuniers
City: Bagneux
State: île-de-france
Zip: 92220
Country: FR
Genomic vision develops novel diagnostic and drug discovery solutions based on nanotechnology for DNA analysis for cancer and acute diseases.
Contact Phone:
Contact Email:
Listed Exchange:
NYSE Euronext
IPO Date:
4/11/2014
Ticker Symbol:
GV
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 3/2014 | IPO | $23M | 12/2005 | Series A | 1 | $2.4M |
Societe Generale Asset Management Societe Generale Asset Management |
7/2008 | Series B | 2 | $6.3M |
Societe Generale Asset Management Vesalius Biocapital Partners Vesalius Biocapital Partners Societe Generale Asset Management Vesalius Biocapital Partners Vesalius Biocapital Partners |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|